|
Anti-TSLP antibody shows promise for treating allergic asthma
ModernMedicine Investigators divided 31 patients with mild allergic asthma into 2 groups: 1 group received 3 monthly doses of AMG 157, an anti-TSLP monoclonal immunoglobulin, and the other, placebo. They conducted allergen challenges on days 42 and 84 of the … |
View full post on asthma – Google News